Researchers have found that some particularly aggressive lung cancer cells can develop their own electric network, like that seen in the body's nervous system.

Researchers from the Francis Crick Institute have found that some particularly aggressive lung cancer cells can develop their own electric network, like that seen in the body's nervous system.

Small cell lung cancer (SCLC) accounts for about 15% of lung cancer cases and is categorized into limited and extensive stages. Treatment options include radiation, chemotherapy, and immunotherapy ...

SGMC Health has successfully performed its first robotic-assisted lung biopsy using the state-of-the-art Ion robot. The ...

Collaboration focuses on launching an AI-powered biomarker prediction panel targeting actionable biomarkers to revolutionize lung cancer diagnostics and enable commercialization of a diagnostic panel.

Heather Wakelee, MD, Stanford University, discusses the pros and cons of different durations of immunotherapy in non-small cell lung cancer (NSCLC) and the future outlook for patient-specific care.

When added to chemotherapy, researchers found no significant difference in overall or progression-free survival between PD-1 ...

Guardant Health is overcoming skepticism with new cancer tests. Learn why GH stock is a buy, with strong growth and a shift ...

Biopsy results confirmed the presence of non-small cell lung cancer (NSCLC). Though the news was difficult to process, the early discovery offered a hopeful outlook. However, a critical next step ...

Biopsy results confirmed the presence of non-small cell lung cancer (NSCLC). Though the news was difficult to process, the early discovery offered a hopeful outlook. However, a critical next step ...